The First World Consensus Conference on Pancreas Transplantation provided 49 jury deliberations regarding the impact of pancreas transplantation on the treatment of diabetic patients, and 110 experts’ recommendations for the practice of pancreas transplantation. The main message from this consensus conference is that both simultaneous pancreas-kidney transplantation (SPK) and pancreas transplantation alone can improve long-term patient survival, and all types of pancreas transplantation dramatically improve the quality of life of recipients. Pancreas transplantation may also improve the course of chronic complications of diabetes, depending on their severity. Therefore, the advantages of pancreas transplantation appear to clearly surpass potential disadvantages. Pancreas after kidney transplantation increases the risk of mortality only in the early period after transplantation, but is associated with improved life expectancy thereafter. Additionally, preemptive SPK, when compared to SPK performed in patients undergoing dialysis, appears to be associated with improved outcomes. Time on dialysis has negative prognostic implications in SPK recipients. Increased long-term survival, improvement in the course of diabetic complications, and amelioration of quality of life justify preferential allocation of kidney grafts to SPK recipients. Audience discussions and live voting are available online at the following URL address: http://mediaeventi.unipi.it/category/1st-world-consensus-conference-of-pancreas-transplantation/246.

First World Consensus Conference on pancreas transplantation: Part II – recommendations

Boggi U.;Cupisti A.;Kauffmann E. F.;Marselli L.;Miccoli M.;Napoli N.;Terrenzio C.;Marchetti P.;
2021-01-01

Abstract

The First World Consensus Conference on Pancreas Transplantation provided 49 jury deliberations regarding the impact of pancreas transplantation on the treatment of diabetic patients, and 110 experts’ recommendations for the practice of pancreas transplantation. The main message from this consensus conference is that both simultaneous pancreas-kidney transplantation (SPK) and pancreas transplantation alone can improve long-term patient survival, and all types of pancreas transplantation dramatically improve the quality of life of recipients. Pancreas transplantation may also improve the course of chronic complications of diabetes, depending on their severity. Therefore, the advantages of pancreas transplantation appear to clearly surpass potential disadvantages. Pancreas after kidney transplantation increases the risk of mortality only in the early period after transplantation, but is associated with improved life expectancy thereafter. Additionally, preemptive SPK, when compared to SPK performed in patients undergoing dialysis, appears to be associated with improved outcomes. Time on dialysis has negative prognostic implications in SPK recipients. Increased long-term survival, improvement in the course of diabetic complications, and amelioration of quality of life justify preferential allocation of kidney grafts to SPK recipients. Audience discussions and live voting are available online at the following URL address: http://mediaeventi.unipi.it/category/1st-world-consensus-conference-of-pancreas-transplantation/246.
2021
Boggi, U.; Vistoli, F.; Andres, A.; Arbogast, H. P.; Badet, L.; Baronti, W.; Bartlett, S. T.; Benedetti, E.; Branchereau, J.; Burke, G. W.; Buron, F.; Caldara, R.; Cardillo, M.; Casanova, D.; Cipriani, F.; Cooper, M.; Cupisti, A.; Davide, J.; Drachenberg, C.; de Koning, E. J. P.; Ettorre, G. M.; Fernandez Cruz, L.; Fridell, J. A.; Friend, P. J.; Furian, L.; Gaber, O. A.; Gruessner, A. C.; Gruessner, R. W. G.; Gunton, J. E.; Han, D. -J.; Iacopi, S.; Kauffmann, E. F.; Kaufman, D.; Kenmochi, T.; Khambalia, H. A.; Lai, Q.; Langer, R. M.; Maffi, P.; Marselli, L.; Menichetti, F.; Miccoli, M.; Mittal, S.; Morelon, E.; Napoli, N.; Neri, F.; Oberholzer, J.; Odorico, J. S.; Ollinger, R.; Oniscu, G.; Orlando, G.; Ortenzi, M.; Perosa, M.; Perrone, V. G.; Pleass, H.; Redfield, R. R.; Ricci, C.; Rigotti, P.; Paul Robertson, R.; Ross, L. F.; Rossi, M.; Saudek, F.; Scalea, J. R.; Schenker, P.; Secchi, A.; Socci, C.; Sousa Silva, D.; Squifflet, J. P.; Stock, P. G.; Stratta, R. J.; Terrenzio, C.; Uva, P.; Watson, C. J. E.; White, S. A.; Marchetti, P.; Kandaswamy, R.; Berney, T.
File in questo prodotto:
File Dimensione Formato  
Am J Transplant 2021 part II.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 2.77 MB
Formato Adobe PDF
2.77 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1146419
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 30
social impact